Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell–Suppressor Mechanisms

Keyphrases

• Psoriasis 100%
• Myeloid-derived Suppressor Cells 100%
• DC-HIL 50%
• T Cells 20%
• Interleukin-17 (IL-17) 20%
• Psoriatic 20%
• Disease Severity 10%
• Regulatory Mechanism 10%
• Dendritic Cells 10%
• Inducible Nitric Oxide Synthase 10%
• Healthy Controls 10%
• Control Subjects 10%
• Melanoma 10%
• Significant Relationship 10%
• Index Score 10%
• Cellular Level 10%
• Heparan Sulfate Proteoglycans 10%
• Untreated Patients 10%
• Functional Properties 10%
• Cell-Associated 10%
• Severity Index 10%
• Allogeneic T Cells 10%
• CD14+ 10%
• Area Index 10%
• Arginase 10%
• Autologous T Cell 10%
• Psoriasis Area 10%
• Psoriasis Severity 10%
• Functional Deficiency 10%
• Suppression Mechanism 10%
• Integrin Ligands 10%
• Melanoma Patients 10%
• Inflammatory Skin Diseases 10%
• Psoriatic Patients 10%
• Psoriasis Disease 10%
• Psoriasis Vulgaris 10%

Biochemistry, Genetics and Molecular Biology

• Myeloid 100%
• T Cell 30%
• Interleukin 17 20%
• Mediator 10%
• Nitric Oxide Synthase 10%
• Proteoglycan 10%
• Heparan Sulfate 10%
• Integrin 10%
• CD14 10%
• Dendritic Cell 10%
• Regulatory T Cell 10%
• Cell Level 10%
• Arginase 10%

Immunology and Microbiology

• Myeloid-Derived Suppressor Cell 100%
• T Cell 30%
• Interleukin 17 20%
• Dendritic Cell 10%
• Mediator 10%
• Regulatory T Cell 10%
• CD14 10%
• Cell Level 10%
• Integrin 10%
• Dermatitis 10%